COVID-19 Bending the Curve: The Path to a Vaccine

Description

For this series, we are bringing together top-rated medical professionals, industry experts, patient advocates and policymakers to update our audience on the latest advancements to combat the virus. In this first event, our focus will be innovation and treatment; we will explore from three perspectives how our country can accelerate research and innovation toward treatments for patients suffering from COVID-19. The following installments will focus on the path to a vaccine and the long-term impact of this crisis on health care policy.
 
McClatchy’s “COVID-19: Bending the Curve” series is designed to be a true exchange of ideas, in a civil forum focused on solutions. With more than 15,000 stories on the COVID-19 crisis to date, McClatchy’s newsrooms have been delivering comprehensive coverage of this pandemic, reaching over 60 million readers and viewers who look to us for essential journalism. These events will provide a unique opportunity to reach those state and local audiences across the country, as it will be livestreamed simultaneously to all of McClatchy’s 30 news sites.
 
The event series is being underwritten by PhRMA. Learn more.